Acanthosis Nigricans During Treatment With Aripiprazole
Publication Date
2014
Journal Title
Am J Ther
Abstract
Aripiprazole is typically regarded as a metabolically sparing agent, in contrast to other second-generation antipsychotics, which are widely known to lead to weight gain and increase the cardiometabolic risk. We report for the first time the emergence of Acanthosis nigricans, a dermatological correlate of insulin resistance, during treatment with aripiprazole in an adolescent with a family history of diabetes mellitus.
Volume Number
21
Issue Number
3
Pages
E90-E93
Document Type
Article
EPub Date
2012/09/27
Status
Faculty, Northwell Researcher
Facility
School of Medicine; Northwell Health
Primary Department
General Internal Medicine
Additional Departments
Psychiatry; Molecular Medicine
PMID
DOI
10.1097/MJT.0b013e3182491e29